Menopause
WeightWatchers debuts menopause programme with Queen Latifah

WeightWatchers has launched a new menopause support programme with Grammy and Emmy Award-winning, Oscar-nominated actress and health advocate Queen Latifah as its first spokeswoman.
The programme combines medical care, nutrition guidance, fitness support and community access for women from perimenopause through post-menopause.
WW International (NASDAQ: WW) developed the plan with physicians, menopause specialists and fitness experts to address weight management and symptoms during this life stage.
Queen Latifah said: “Menopause has been a new journey for me—one that’s changed how I see and care for my body.
“It’s shown me how important it is for women to have support that truly understands this stage of life.
“That’s why I’m proud to be the spokesperson for WeightWatchers’ new programme.
“For decades, WeightWatchers has helped women live healthier, more confident lives, and now they’re once again leading the way with care designed for menopause.”
The programme includes consultations with clinicians trained in menopause care, individualised care plans and access to treatments including hormone replacement therapy (HRT).
It also offers GLP-1 medications and other evidence-based options, a tailored version of the Points Programme, fitness designed for strength and stability, and workshops led by coaches familiar with this stage of life.
GLP-1s are medicines developed for diabetes that can also aid weight loss.
Tara Comonte, chief executive officer of WeightWatchers, said: “For more than six decades, WeightWatchers has evolved with the science to meet the changing needs of our members.
“With this first-of-its-kind menopause programme we’re proud to deliver comprehensive care in a single plan, bringing together medical expertise, science-backed nutrition, lifestyle tools and a supportive community.
“This programme sets a new standard for women’s health, helping millions feel healthier and more confident as they navigate menopause and beyond.”
The company cites studies showing women of menopausal age following WeightWatchers’ nutritional guidance lost nearly four times more weight than those managing independently.
Women enrolled in WeightWatchers Clinic lost on average 18.6 per cent of their body weight (40.1 lbs) in one year.
Research from the Mayo Clinic found postmenopausal women receiving hormone therapy combined with GLP-1 semaglutide achieved around 30 per cent greater weight loss than those using the GLP-1 alone.
Menopause2 weeks agoPerimenopause misinformation ‘putting women at risk’
Hormonal health3 weeks agoNHS urged to update website following renaming of PCOS
Insight4 weeks agoPCOS renamed after decade-long campaign to end ‘cyst’ misconception
News1 week agoWomen still being failed when they reach menopause, experts say
Entrepreneur2 weeks agoWomen’s Health Innovation Summit opens submissions for 2026 Innovation Showcase
Diagnosis4 weeks agoArtera receives FDA Clearance for breast cancer platform
News2 weeks agoThree menopause innovators shortlisted for Femtech World Award
Fertility3 weeks agoAI could transform ovarian care through personalisation, study finds


















